Impact of 'mild' asthma on health outcomes: findings of a systematic search of the literature
- PMID: 16210094
- DOI: 10.1016/j.rmed.2005.03.020
Impact of 'mild' asthma on health outcomes: findings of a systematic search of the literature
Abstract
The present bibliographic review shows that patients considered to have mild asthma often suffer impairment in quality of life (QoL) and use considerable scheduled and unscheduled health care resources. I found that asthma investigators used no consistent classification scheme for asthma severity, and the level of agreement amongst specialists when categorizing patients with asthma was low. Asthma severity has been classified using a wide range of parameters including medication use, asthma symptoms, lung function, hospitalizations and incidence of exacerbations. Most studies showed a general association between asthma severity and health-related quality of life (HRQoL) such that patients with severe disease suffered greater impairment. However, few patients with mild asthma enjoyed unimpaired HRQoL. Indeed depression and impaired HRQoL were reported as frequently in patients with mild asthma as in those with more severe disease. Although in general severe patients used the most health care resources, even patients with mild asthma used considerable health care resources including emergency room care and hospitalizations. In summary, the term 'mild' when applied to asthma is potentially misleading given the impaired HRQoL and avoidable health care utilization prevalent amongst such patients. The application of disease severity classification in clinical asthma management has not been validated. It may now be appropriate to examine these classifications more critically in order to determine if they have clinical or research usefulness. By contrast, the strategy of treating to achieve disease control has been validated and offers the advantage of simplicity in its application.
Similar articles
-
Improving asthma-related health outcomes among low-income, multiethnic, school-aged children: results of a demonstration project that combined continuous quality improvement and community health worker strategies.Pediatrics. 2007 Oct;120(4):e902-11. doi: 10.1542/peds.2006-1805. Pediatrics. 2007. PMID: 17908746
-
Costs and quality of life of multiple sclerosis in Switzerland.Eur J Health Econ. 2006 Sep;7 Suppl 2:S86-95. doi: 10.1007/s10198-006-0383-9. Eur J Health Econ. 2006. PMID: 17310338
-
Severity assessment in asthma: An evolving concept.J Allergy Clin Immunol. 2005 Nov;116(5):990-5. doi: 10.1016/j.jaci.2005.08.018. Epub 2005 Oct 3. J Allergy Clin Immunol. 2005. PMID: 16275365
-
Socioeconomic outcomes in work-exacerbated asthma.Curr Opin Allergy Clin Immunol. 2007 Jun;7(3):236-41. doi: 10.1097/ACI.0b013e3280b10d68. Curr Opin Allergy Clin Immunol. 2007. PMID: 17489041 Review.
-
Health-related quality of life in critically ill patients: how to score and what is the clinical impact?Curr Opin Crit Care. 2009 Oct;15(5):425-30. doi: 10.1097/MCC.0b013e32833079e4. Curr Opin Crit Care. 2009. PMID: 19623059 Review.
Cited by
-
Risk Factors Associated with Asthma Control and Quality of Life in Patients with Mild Asthma Without Preventer Treatment, a Cross-Sectional Study.J Asthma Allergy. 2024 Jul 9;17:621-632. doi: 10.2147/JAA.S460051. eCollection 2024. J Asthma Allergy. 2024. PMID: 39006240 Free PMC article.
-
Short-acting β2-agonist prescription patterns for asthma management in the SABINA III primary care cohort.NPJ Prim Care Respir Med. 2022 Sep 29;32(1):37. doi: 10.1038/s41533-022-00295-7. NPJ Prim Care Respir Med. 2022. PMID: 36175556 Free PMC article.
-
Role of the TGF-β cytokine and its gene polymorphisms in asthma etiopathogenesis.Front Allergy. 2025 Jan 30;6:1529071. doi: 10.3389/falgy.2025.1529071. eCollection 2025. Front Allergy. 2025. PMID: 39949968 Free PMC article. Review.
-
International differences in asthma guidelines for children.Int Arch Allergy Immunol. 2009;148(4):265-78. doi: 10.1159/000170380. Epub 2008 Nov 11. Int Arch Allergy Immunol. 2009. PMID: 19001786 Free PMC article. Review.
-
The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada.Allergy Asthma Clin Immunol. 2021 Oct 12;17(1):108. doi: 10.1186/s13223-021-00610-w. Allergy Asthma Clin Immunol. 2021. PMID: 34641954 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical